- Home
- HNST vs AURA Comparison
HNST vs AURA Comparison
Compare HNST & AURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HNST
- AURA
- Stock Information
- Founded
- HNST 2012
- AURA 2007
- Country
- HNST United States
- AURA United States
- Employees
- HNST N/A
- AURA N/A
- Industry
- HNST Catalog/Specialty Distribution
- AURA Biotechnology: Pharmaceutical Preparations
- Sector
- HNST Consumer Discretionary
- AURA Health Care
- Exchange
- HNST Nasdaq
- AURA Nasdaq
- Market Cap
- HNST 405.0M
- AURA 396.8M
- IPO Year
- HNST 2021
- AURA 2021
- Fundamental
- Price
- HNST $3.64
- AURA $5.67
- Analyst Decision
- HNST Buy
- AURA Strong Buy
- Analyst Count
- HNST 5
- AURA 7
- Target Price
- HNST $6.75
- AURA $22.29
- AVG Volume (30 Days)
- HNST 4.1M
- AURA 253.2K
- Earning Date
- HNST 11-11-2025
- AURA 11-11-2025
- Dividend Yield
- HNST N/A
- AURA N/A
- EPS Growth
- HNST N/A
- AURA N/A
- EPS
- HNST 0.06
- AURA N/A
- Revenue
- HNST $389,783,000.00
- AURA N/A
- Revenue This Year
- HNST $6.68
- AURA N/A
- Revenue Next Year
- HNST $4.81
- AURA N/A
- P/E Ratio
- HNST $59.92
- AURA N/A
- Revenue Growth
- HNST 9.58
- AURA N/A
- 52 Week Low
- HNST $3.49
- AURA $4.35
- 52 Week High
- HNST $8.97
- AURA $12.38
- Technical
- Relative Strength Index (RSI)
- HNST 42.48
- AURA 37.97
- Support Level
- HNST $3.60
- AURA $5.80
- Resistance Level
- HNST $3.86
- AURA $6.62
- Average True Range (ATR)
- HNST 0.18
- AURA 0.30
- MACD
- HNST -0.00
- AURA 0.00
- Stochastic Oscillator
- HNST 28.86
- AURA 0.00
About HNST The Honest Company Inc.
The Honest Co Inc is a digitally-native consumer products company to makes purpose-driven consumer products designed for all people. It is an omnichannel brand, ensuring its products are available wherever its consumers shop through the company's Retail and Digital channels. It has three product categories namely; Diapers and Wipes, Skin and Personal Care, and Household and Wellness, out of which the majority of its revenue is generated from the sale of diapers and wipes. The company operates only in the United States.
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.